Cambiar Investors LLC Has $11.51 Million Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

→ AI finds its first serious application (From Wall Street Star) (Ad)

Cambiar Investors LLC boosted its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 15.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 323,432 shares of the medical instruments supplier's stock after acquiring an additional 42,685 shares during the quarter. Cambiar Investors LLC owned 0.15% of DENTSPLY SIRONA worth $11,511,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in XRAY. Bar Harbor Wealth Management bought a new position in shares of DENTSPLY SIRONA during the 4th quarter valued at $4,931,000. Andra AP fonden lifted its holdings in shares of DENTSPLY SIRONA by 20.3% during the 3rd quarter. Andra AP fonden now owns 302,700 shares of the medical instruments supplier's stock valued at $10,340,000 after buying an additional 51,100 shares during the period. Envestnet Asset Management Inc. lifted its holdings in shares of DENTSPLY SIRONA by 98.1% during the 3rd quarter. Envestnet Asset Management Inc. now owns 347,220 shares of the medical instruments supplier's stock valued at $11,861,000 after buying an additional 171,958 shares during the period. Mirabella Financial Services LLP bought a new position in shares of DENTSPLY SIRONA during the 3rd quarter valued at $802,000. Finally, PEAK6 Investments LLC bought a new position in shares of DENTSPLY SIRONA during the 3rd quarter valued at $203,000. 95.70% of the stock is owned by institutional investors.


Analyst Ratings Changes

Several equities analysts have recently weighed in on XRAY shares. Needham & Company LLC reissued a "buy" rating and set a $42.00 price target on shares of DENTSPLY SIRONA in a report on Thursday, February 29th. Piper Sandler upped their price objective on DENTSPLY SIRONA from $31.00 to $35.00 and gave the stock a "neutral" rating in a research note on Friday, January 12th. Leerink Partnrs restated an "outperform" rating on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. SVB Leerink started coverage on DENTSPLY SIRONA in a research note on Monday, February 26th. They issued an "outperform" rating and a $42.00 price objective for the company. Finally, StockNews.com upgraded DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research note on Friday, January 19th. Three equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $39.50.

View Our Latest Stock Report on DENTSPLY SIRONA

DENTSPLY SIRONA Price Performance

XRAY stock traded up $0.39 during trading on Friday, reaching $32.31. The company's stock had a trading volume of 3,348,568 shares, compared to its average volume of 4,728,746. DENTSPLY SIRONA Inc. has a 1 year low of $26.27 and a 1 year high of $43.24. The company has a quick ratio of 0.95, a current ratio of 1.38 and a debt-to-equity ratio of 0.55. The company has a market capitalization of $6.70 billion, a P/E ratio of -52.11, a price-to-earnings-growth ratio of 1.31 and a beta of 0.98. The company's fifty day moving average is $33.34 and its 200-day moving average is $33.02.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.01. DENTSPLY SIRONA had a positive return on equity of 11.14% and a negative net margin of 3.33%. The firm had revenue of $1.01 billion for the quarter, compared to analysts' expectations of $972.61 million. During the same period in the previous year, the firm posted $0.46 earnings per share. The business's revenue was up 3.0% compared to the same quarter last year. On average, research analysts expect that DENTSPLY SIRONA Inc. will post 2.05 earnings per share for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 12th. Stockholders of record on Friday, March 29th will be issued a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 1.98%. This is a boost from DENTSPLY SIRONA's previous quarterly dividend of $0.14. The ex-dividend date of this dividend is Wednesday, March 27th. DENTSPLY SIRONA's payout ratio is -103.22%.

DENTSPLY SIRONA Company Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Read More

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Should you invest $1,000 in DENTSPLY SIRONA right now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Featured Articles and Offers

Search Headlines: